These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 17346697

  • 21. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo.
    Chen H, Takahashi S, Imamura M, Okutani E, Zhang ZG, Chayama K, Chen BA.
    Chin Med J (Engl); 2007 May 20; 120(10):898-904. PubMed ID: 17543180
    [Abstract] [Full Text] [Related]

  • 22. [Antitumor activity of mitoxantrone-nanosphere against murine liver tumor H22].
    Yang YX, Zhu L, He X, Bao DY, Bao X.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan 20; 35(1):68-70. PubMed ID: 14981819
    [Abstract] [Full Text] [Related]

  • 23. [Effect of Xiaochaihu decoction and different herbal formulation of component on inhibiting H22 liver cancer in mice and enhancing immune function].
    Li J, Xie M, Gan Y.
    Zhongguo Zhong Yao Za Zhi; 2008 May 20; 33(9):1039-44. PubMed ID: 18652353
    [Abstract] [Full Text] [Related]

  • 24. [Synthesis and antitumor activities of triazacyclodecane and its platinum (II) complex].
    Zhou SS, Zhang QY, Qin K, Lu CH, Xie FX.
    Yao Xue Xue Bao; 2008 May 20; 43(5):490-4. PubMed ID: 18717336
    [Abstract] [Full Text] [Related]

  • 25. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
    Li X, Li R, Qian X, Ding Y, Tu Y, Guo R, Hu Y, Jiang X, Guo W, Liu B.
    Eur J Pharm Biopharm; 2008 Nov 20; 70(3):726-34. PubMed ID: 18634874
    [Abstract] [Full Text] [Related]

  • 26. Identification, characterization and potent antitumor activity of ECO-4601, a novel peripheral benzodiazepine receptor ligand.
    Gourdeau H, McAlpine JB, Ranger M, Simard B, Berger F, Beaudry F, Farnet CM, Falardeau P.
    Cancer Chemother Pharmacol; 2008 May 20; 61(6):911-21. PubMed ID: 17622531
    [Abstract] [Full Text] [Related]

  • 27. Development and validation of a quantitative cell-based bioassay for comparing the pharmacokinetic profiles of two recombinant erythropoietic proteins in serum.
    Wei X, Grill DS, Heatherington AC, Swanson SJ, Gupta S.
    J Pharm Biomed Anal; 2007 Jan 17; 43(2):666-76. PubMed ID: 16971087
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T, Wartmann M, Brueggen J, Allegrini PR, Floersheimer A, Maira M, McSheehy PM.
    Cancer Chemother Pharmacol; 2008 Nov 17; 62(6):1045-54. PubMed ID: 18301895
    [Abstract] [Full Text] [Related]

  • 29. Inhibitory effects of vegetable and fruit ferment liquid on tumor growth in Hepatoma-22 inoculation model.
    Lu M, Toshima Y, Wu XL, Zhang X, Cai YQ.
    Asia Pac J Clin Nutr; 2007 Nov 17; 16 Suppl 1():443-6. PubMed ID: 17392147
    [Abstract] [Full Text] [Related]

  • 30. Predicting the active doses in humans from animal studies: a novel approach in oncology.
    Rocchetti M, Simeoni M, Pesenti E, De Nicolao G, Poggesi I.
    Eur J Cancer; 2007 Aug 17; 43(12):1862-8. PubMed ID: 17604156
    [Abstract] [Full Text] [Related]

  • 31. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo].
    Zhou YL, Hu WX, Lü YP, Qiu LN, Wang WS, Yang ZY, Liu JD, Rao GW.
    Yao Xue Xue Bao; 2007 Jan 17; 42(1):26-34. PubMed ID: 17520803
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
    Zhang AL, Russell PJ, Knittel T, Milross C.
    Prostate; 2007 Nov 01; 67(15):1630-40. PubMed ID: 17823933
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Tumor-inhibitory effect and immunomodulatory activity of fullerol C60(OH)x.
    Zhu J, Ji Z, Wang J, Sun R, Zhang X, Gao Y, Sun H, Liu Y, Wang Z, Li A, Ma J, Wang T, Jia G, Gu Y.
    Small; 2008 Aug 01; 4(8):1168-75. PubMed ID: 18574800
    [Abstract] [Full Text] [Related]

  • 36. Linking antibody Fc domain to endostatin significantly improves endostatin half-life and efficacy.
    Lee TY, Tjin Tham Sjin RM, Movahedi S, Ahmed B, Pravda EA, Lo KM, Gillies SD, Folkman J, Javaherian K.
    Clin Cancer Res; 2008 Mar 01; 14(5):1487-93. PubMed ID: 18316573
    [Abstract] [Full Text] [Related]

  • 37. Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth.
    Hu B, Kou L, Li C, Zhu LP, Fan YR, Wu ZW, Wang JJ, Xu GX.
    Cancer Gene Ther; 2009 Aug 01; 16(8):655-63. PubMed ID: 19229287
    [Abstract] [Full Text] [Related]

  • 38. Measurement of in vivo BCR-ABL kinase inhibition to monitor imatinib-induced target blockade and predict response in chronic myeloid leukemia.
    White D, Saunders V, Grigg A, Arthur C, Filshie R, Leahy MF, Lynch K, To LB, Hughes T.
    J Clin Oncol; 2007 Oct 01; 25(28):4445-51. PubMed ID: 17906206
    [Abstract] [Full Text] [Related]

  • 39. [Preparation of long-circulating nolatrexed dihydrochloride liposomes and its antitumor activity].
    Chen SZ, Wang SM, Zhang JR.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar 01; 28(3):403-5. PubMed ID: 18359701
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.